Results 231 to 240 of about 1,243,857 (290)
Some of the next articles are maybe not open access.

Amyloid Beta: The Alternate Hypothesis

Current Alzheimer Research, 2006
Alzheimer disease (AD) is a devastating condition and patients, caregivers, clinicians, and scientists are eager to decipher the underlying disease mechanism and, thereafter, target this therapeutically. Most investigators studying the underlying cause of AD have focused on amyloid-beta (Abeta) such that the Amyloid Cascade Hypothesis is the ...
Hyoung-gon, Lee   +4 more
openaire   +2 more sources

Amyloid Beta

2019
Alzheimer's disease (AD), exhibiting accumulation of amyloid beta (Aβ) peptide as a foremost protagonist, is one of the top five causes of deaths. It is a neurodegenerative disorder (ND) that causes a progressive decline in memory and cognitive abilities. It is characterized by deposition of Aβ plaques and neurofibrillary tangles (NFTs) in the neurons,
Abhinav Anand   +3 more
openaire   +1 more source

Amyloid beta antagonizes insulin promoted secretion of the amyloid beta protein precursor

Journal of Alzheimer's Disease, 2002
Amyloid β (Aβ) peptides are direct competitive inhibitors of insulin binding and action [25]. We demonstrate that Aβ peptides can inhibit the effect of insulin on the metabolic processing of the amyloid β protein precursor (AβPP). As evidence emerges concerning the role of insulin and insulin like growth factors (IGFs) in learning and memory, recent ...
Xie, Ling   +4 more
openaire   +2 more sources

Amyloid beta.

The international journal of biochemistry & cell biology, 1999
Amyloid beta (A beta) is a 39-43 residue amyloidogenic peptide that is deposited into the extracellular amyloid plaques which characterize an Alzheimer's disease (AD) brain. A beta is derived from the amyloid precursor protein (APP) and undergoes a toxic conformational change (gain of toxic function).
R, Cappai, A R, White
openaire   +1 more source

Cholesterol, Lipids, Amyloid Beta, and Alzheimers

Current Alzheimer Research, 2010
High levels of cholesterol have been proposed as a risk factor for Alzheimer's disease (AD). Polymorphism of genes encoding proteins that regulate cholesterol metabolism have also been associated with the frequency of Alzheimer's development. Some studies have shown that cholesterol-lowering drugs reduce the frequency of AD development.
Mun'delanji, Vestergaard   +3 more
openaire   +2 more sources

Cholesterol Trafficking and Amyloid Beta Peptides

Pharmacopsychiatry, 2003
Currently, there is much interest in the association between cholesterol and Alzheimer's disease. An especially important aspect of this association is the relationship between amyloid beta-peptide (Abeta) and cholesterol that can be described as a reciprocal process.
W G, Wood, U, Igbavboa
openaire   +2 more sources

Neprilysin and Amyloid Beta Peptide Degradation

Current Alzheimer Research, 2008
Neprilysin is a zinc metalloendopeptidase with relatively broad substrate specificity. The enzyme is localized to the plasma membrane of cells where it can function to degrade extracellular peptides. Structural studies show that neprilysin preferentially cleaves peptides on the amino side of hydrophobic amino acids.
Louis B, Hersh, David W, Rodgers
openaire   +2 more sources

Amyloid-beta aggregation.

Neuro-degenerative diseases, 2007
Alzheimer's disease (AD) is the most prevalent neurodegenerative disease in the growing population of elderly people. A hallmark of AD is the accumulation of plaques in the brain of AD patients. The plaques predominantly consist of aggregates of amyloid-beta (Abeta), a peptide of 39-42 amino acids generated in vivo by specific, proteolytic cleavage of ...
Finder VH, Glockshuber R
openaire   +2 more sources

Amyloid Beta Neurotoxicity

2017
1.
Ho, WL   +6 more
openaire   +1 more source

Amyloid-Beta

2010
Jean-Michel Scherrmann   +199 more
openaire   +1 more source

Home - About - Disclaimer - Privacy